These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24490130)

  • 1. NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC).
    Almeida LO; Abrahao AC; Rosselli-Murai LK; Giudice FS; Zagni C; Leopoldino AM; Squarize CH; Castilho RM
    FEBS Open Bio; 2014; 4():96-104. PubMed ID: 24490130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone modifications: Targeting head and neck cancer stem cells.
    Le JM; Squarize CH; Castilho RM
    World J Stem Cells; 2014 Nov; 6(5):511-25. PubMed ID: 25426249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
    Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
    Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC).
    Morgan EL; Toni T; Viswanathan R; Robbins Y; Yang X; Cheng H; Gunti S; Huynh A; Sowers AL; Mitchell JB; Allen CT; Chen Z; Van Waes C
    Cell Death Differ; 2023 May; 30(5):1382-1396. PubMed ID: 37055579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HDAC6 Protein Enhances Bortezomib-induced Apoptosis in Head and Neck Squamous Cell Carcinoma (HNSCC) by Reducing Autophagy.
    Chang I; Wang CY
    J Biol Chem; 2016 Aug; 291(35):18199-209. PubMed ID: 27369083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKβ protein of the NFκB pathway.
    Duarte VM; Han E; Veena MS; Salvado A; Suh JD; Liang LJ; Faull KF; Srivatsan ES; Wang MB
    Mol Cancer Ther; 2010 Oct; 9(10):2665-75. PubMed ID: 20937593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer.
    Giudice FS; Pinto DS; Nör JE; Squarize CH; Castilho RM
    PLoS One; 2013; 8(3):e58672. PubMed ID: 23527004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101.
    Duan J; Friedman J; Nottingham L; Chen Z; Ara G; Van Waes C
    Mol Cancer Ther; 2007 Jan; 6(1):37-50. PubMed ID: 17237265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Squarize CH; Castilho RM; Sriuranpong V; Pinto DS; Gutkind JS
    Neoplasia; 2006 Sep; 8(9):733-46. PubMed ID: 16984731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with cisplatin and the tankyrase inhibitor XAV-939 increases cytotoxicity, abrogates cancer-stem-like cell phenotype and increases chemosensitivity of head-and-neck squamous-cell carcinoma cells.
    Roy S; Roy S; Kar M; Chakraborty A; Kumar A; Delogu F; Asthana S; Hande MP; Banerjee B
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Oct; 846():503084. PubMed ID: 31585633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.
    De Schutter H; Kimpe M; Isebaert S; Nuyts S
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):904-12. PubMed ID: 19215824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma.
    Roy S; Roy S; Kar M; Padhi S; Saha A; Anuja K; Banerjee B
    J Oral Pathol Med; 2018 May; 47(5):492-501. PubMed ID: 29575240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p38 Mitogen-activated protein kinase modulates cisplatin resistance in Head and Neck Squamous Cell Carcinoma cells.
    Roy S; Roy S; Anuja K; Thakur S; Akhter Y; Padhi S; Banerjee B
    Arch Oral Biol; 2021 Feb; 122():104981. PubMed ID: 33302041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
    Castilho RM; Squarize CH; Almeida LO
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing the role of epigenetic histone modification in targeting head and neck squamous cell carcinoma.
    Suchanti S; Stephen BJ; Awasthi S; Awasthi SK; Singh G; Singh A; Mishra R
    Epigenomics; 2022 Mar; 14(5):279-293. PubMed ID: 35184601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer.
    Huang Z; Li H; Huang Q; Chen D; Han J; Wang L; Pan C; Chen W; House MG; Nephew KP; Guo Z
    Mol Carcinog; 2014 Oct; 53(10):777-86. PubMed ID: 23661500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PS-341 and histone deacetylase inhibitor synergistically induce apoptosis in head and neck squamous cell carcinoma cells.
    Kim J; Guan J; Chang I; Chen X; Han D; Wang CY
    Mol Cancer Ther; 2010 Jul; 9(7):1977-84. PubMed ID: 20571067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition.
    Liao J; Yang Z; Carter-Cooper B; Chang ET; Choi EY; Kallakury B; Liu X; Lapidus RG; Cullen KJ; Dan H
    Clin Exp Metastasis; 2020 Apr; 37(2):283-292. PubMed ID: 32020377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SET oncoprotein accumulation regulates transcription through DNA demethylation and histone hypoacetylation.
    Almeida LO; Neto MPC; Sousa LO; Tannous MA; Curti C; Leopoldino AM
    Oncotarget; 2017 Apr; 8(16):26802-26818. PubMed ID: 28460463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancer.
    Li Z; Yang Z; Lapidus RG; Liu X; Cullen KJ; Dan HC
    Am J Cancer Res; 2015; 5(10):3098-110. PubMed ID: 26693062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.